Epidemiology and Natural History in Japan
暂无分享,去创建一个
Y. Nakanuma | K. Harada | K. Okazaki | T. Seki | H. Tsubouchi | T. Nakano | H. Ishibashi | J. Hirohara
[1] Y. Nakanuma,et al. Incidence of and risk factors for hepatocellular carcinoma in primary biliary cirrhosis: National data from Japan , 2013, Hepatology.
[2] R. Poupon. Primary biliary cirrhosis: a 2010 update. , 2010, Journal of hepatology.
[3] T. Seki,et al. Prediction of prognosis of primary biliary cirrhosis in Japan. , 2008, Liver.
[4] M. Omata,et al. Long-term prognosis of primary biliary cirrhosis (PBC) in Japan and analysis of the factors of stage progression in asymptomatic PBC (a-PBC). , 2002, Hepatology research : the official journal of the Japan Society of Hepatology.
[5] A. Terashi,et al. A lipid lowering drug (bezafibrate) has a favorable effect on liver enzymes (Al-P and gamma-GTP). , 1996, Nihon Ika Daigaku zasshi.
[6] Y. Chrétien,et al. IS URSODEOXYCHOLIC ACID AN EFFECTIVE TREATMENT FOR PRIMARY BILIARY CIRRHOSIS? , 1987, The Lancet.
[7] Kyoichi Inoue,et al. Primary biliary cirrhosis in japan: National survey by the subcommittee on autoimmune hepatitis , 1985, Gastroenterologia Japonica.
[8] P. Scheuer. Primary biliary cirrhosis. , 1967, Proceedings of the Royal Society of Medicine.
[9] H. Kunkel,et al. Primary biliary cirrhosis. , 1950, Medicine.